entity

PARP1, SIRT1/3, NAD+

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARP1, SIRT1/3, NAD+: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

1Hypotheses

1Analyses

1Outgoing

0Incoming

0Experiments

1Debates

No AI portrait yet

Outgoing (1)

Target	Relation	Type	Str
metabolomics	implicates_in	disease	0.52

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
NAD+ Precursor Supplementation to Reverse Poly(ADP-ribose) P	0.520	metabolomics	Metabolomic signatures of neurodegenerat

Mentioning Analyses (1)

Scientific analyses that reference this entity

Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br

metabolomics | 2026-04-16 | 7 hypotheses Top: 0.520

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the key metabolic alterations detectable in brain tissue, CSF, and bloo

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning PARP1, SIRT1/3, NAD+ in their description or question text

No additional research found